DITE, Petr, Martin BLAHO, Martina BOJKOVA, Petr JABANDŽIEV a Lumír KUNOVSKÝ. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences. Digestive Diseases. BASEL: KARGER, 2020, roč. 38, č. 2, s. 143-149. ISSN 0257-2753. Dostupné z: https://dx.doi.org/10.1159/000505366.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Nonalcoholic Fatty Pancreas Disease: Clinical Consequences
Autoři DITE, Petr (203 Česká republika), Martin BLAHO (203 Česká republika), Martina BOJKOVA (203 Česká republika), Petr JABANDŽIEV (203 Česká republika, domácí) a Lumír KUNOVSKÝ (203 Česká republika, garant, domácí).
Vydání Digestive Diseases, BASEL, KARGER, 2020, 0257-2753.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30219 Gastroenterology and hepatology
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.404
Kód RIV RIV/00216224:14110/20:00115602
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1159/000505366
UT WoS 000522852200011
Klíčová slova anglicky Pancreas steatosis; Nonalcoholic fatty pancreas disease; Nonalcoholic steatopancreatitis; Metabolic syndrome; Cardiovascular diseases; Diabetes mellitus; Obesity; Pancreatic carcinoma; Exocrine pancreatic insufficiency
Štítky 14110213, 14110223, 14110317, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 7. 5. 2020 09:02.
Anotace
Metabolic syndrome and its components such as obesity, hypertriglyceridemia, type-2 diabetes mellitus (DM-T2), and arterial hypertension are unequivocally serious problems for every society. This is especially true in economically developed countries where the imbalance in lifestyle between caloric intake and caloric output still gets greater and greater. This fact is not only a concern for the adult population but for children as well. However, metabolic syndrome does not only affect society and health in regards to cardiovascular diseases, it significantly concerns gastroenterology where it is classified as nonalcoholic fatty pancreas disease (NAFPD). The data gained from several trials show that the prevalence of NAFDP is 33% (95% CI 24-41%). When it comes to the diagnostic procedures concerning the presence of pancreatic fat, a whole spectrum of suitable methods are recommended. Probably, the most exact method is the use of magnetic resonance imaging. However, for common clinical practice, the abdominal sonographic examination based on the comparison of the pancreatic parenchymatous echogenity versus renal or hepatic echogenity is used. The clinical consequences of pancreatic steatosis and steatopancreatitis are significant. These diseases are connected with DM-T2 and insulin resistance. In recent years, changes of exocrine pancreatic function, particularly its decrease, have also been described. It is known that there is a close correlation between NAFPD and nonalcoholic hepatic steatosis and also with the increased thickness of aortic intima-media. There is also an important relationship between NAFPD and pancreatic carcinoma. Pancreatic steatosis, and especially its NAFPD form, is a serious state which can be treatable by the possible effective management of metabolic syndrome parameters, including obesity.
VytisknoutZobrazeno: 25. 4. 2024 07:02